A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 232
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ISHLT
Long Form : International Society for Heart and Lung Transplantation
No. Year Title Co-occurring Abbreviation
2020 Epidemiology of Left Ventricular Assist Device infections: findings from a large non-registry cohort. SIRS, VAD
2020 Incidence of Infection and Antimicrobial Consumption in Ventricular Assist Device (VAD) Recipients at the Prince Charles Hospital (TPCH): A Retrospective Analysis. VAD, VADs
2020 Induction immunosuppression strategies and long-term outcomes after heart transplantation. ATG, BAS
2020 Lung transplant programs in developing countries: challenges, solutions, and outcomes. LT
2020 Machine learning helps predict long-term mortality and graft failure in patients undergoing heart transplant. AUC, GBM, GF, OHT
2020 Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients. AMR, dnDSA, DSA, ECP, HLA, MFI
2020 Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system. BOS, CLAD, RAS
2020 Statement From the Society for the Advancement of Transplant Anesthesia: White Paper Advocating Desirable Milestones and Competencies for Anesthesiology Fellowship Training in the Field of Lung Transplantation. SATA
2020 Survival following concomitant aortic valve procedure during left ventricular assist device surgery: an ISHLT Mechanically Assisted Circulatory Support (IMACS) Registry. AoV, IMACS, LVAD
10  2020 The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy. CAV, IVUS, OHT
11  2020 Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies. AMR, OR, pAMR
12  2020 Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients. CAV, COR, ICMP, vFFR
13  2019 A Recipient Risk Prediction Tool for Short-term Mortality After Pediatric Heart Transplantation. HT
14  2019 Assessment of pre-operative psychosocial function among people receiving left ventricular assist devices: A national survey of US LVAD programs. INTERMACS, LVAD, MCS
15  2019 Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry. DBD, DCD, IQR
16  2019 Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. AEs, BSIs, INTERMACS, MCS, UTIs, VAD
17  2019 Extended criteria donor lungs do not impact recipient outcomes in pediatric transplantation. ECD, ECMO, SCD
18  2019 HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices. HF
19  2019 HFSA/SAEM/ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices. HF
20  2019 Indications for lung transplant referral and listing. LAS
21  2019 Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry. DCD, WIT
22  2019 ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study. PGD
23  2019 Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale. CAV, HR
24  2019 Native T1 Mapping in the Diagnosis of Cardiac Allograft Rejection: A Prospective Histologically Validated Study. CMR
25  2019 Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry‒based analysis. CF, CI, LT, OR
26  2019 Primary graft dysfunction after heart transplantation: a thorn amongst the roses. PGD
27  2019 Stem cell secretome attenuates acute rejection in rat lung allotransplant. BMSC-sec
28  2019 Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis. EPPY, INTERMACS, VAD
29  2019 Usefulness of dual imaging stress echocardiography for the diagnosis of coronary allograft vasculopathy in heart transplant recipients. CAV, CRF, DiSE, LAD, WM
30  2019 Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation. CI, HR, LV, RV
31  2019 [Selection of lung transplant candidates in France in 2019]. PAH
32  2018 Bone marrow stem cells modified with human interleukin 10 attenuate acute rejection in rat lung allotransplantation. BMSCs, CsA, hIL-10, I-IIA
33  2018 Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study. ACR, CAV, CI, CMV, HR
34  2018 Donor and recipient risk factor analysis of inferior postheart transplantation outcome in the era of durable mechanical assist devices. HR, LVADs
35  2018 Heart transplantation outcomes for rheumatic heart disease: Analysis of international registry data. DCM, RHD
36  2018 Heart Transplantation Survival and Sex-Related Differences. CAV, OHT
37  2018 How to obtain and maintain favorable results after heart transplantation: keys to success? DRI, IMPACT, MCS
38  2018 Indications for lung resection surgery and lung transplant in South American children with cystic fibrosis. CF, FEV1
39  2018 Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation. CS, OHT
40  2018 Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. ACR, AMR, ddcfDNA, DSA, LTRs
41  2018 Lung transplantation: indications and contraindications. ---
42  2018 Outcomes of adolescent recipients after lung transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry. ---
43  2018 Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors. HT, PGD
44  2018 Selection of Candidates for Lung Transplantation and Controversial Issues. ---
45  2018 The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. MCS
46  2018 The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. MCS
47  2018 The history of lung transplantation in Hong Kong. LAM
48  2018 The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients. CAC, CT, ICA
49  2018 Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review. ACR, cTn, EMB, HT, NPV, PPV, ROC
50  2017 (1,3) beta-D-Glucan in Bronchoalveolar Lavage of Lung Transplant Recipients for the Diagnosis of Invasive Pulmonary Aspergillosis. BAL, BDG, IA, IPA
51  2017 Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. OHT
52  2017 Antibody-mediated rejection in the cardiac allograft: diagnosis, treatment and future considerations. AMR
53  2017 Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†. LOS, PGD
54  2017 Changes in Outcomes of Cardiac AllograftVasculopathy Over 30 Years Following Heart Transplantation. CAV, CI, HR
55  2017 Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society. AMR, PPS
56  2017 Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender. BMI, CI, HR, IWM, OR
57  2017 Evaluation of a Heart Transplant Candidate. MCS, MELD
58  2017 Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. CIM, PACIC
59  2017 Heart Transplantation in Asia. CAV, HF
60  2017 Incidence and Mortality by Cancer in Patients After Lung Transplantation in a Brazilian Institution. ---
61  2017 Lower frequency routine surveillance endomyocardial biopsies after heart transplantation. CAV, RSEMB, stEMB
62  2017 Mechanical circulatory support and heart transplantation in the Asia Pacific region. HF, MCS
63  2017 Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats. ---
64  2017 Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection. ACR, AMR, AUC, DSA, EM, EMBs
65  2017 Prevention and Infection Management in Mechanical Circulatory Support Device Recipients. BTT, DT, MCS
66  2017 Triptolide inhibits CD4+ memory T cell-mediated acute rejection and prolongs cardiac allograft survival in mice. CD, i.p, IFN-gamma, IL, TGF-beta1
67  2016 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). AEPC, ERS, ESC
68  2016 Age-related survival disparity associated with lung transplantation in cystic fibrosis: An analysis of the registry of the International Society for Heart and Lung Transplantation. CF, CI, HR, UNOS, USA
69  2016 Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. ---
70  2016 First Annual IMACS Report: A global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. ---
71  2016 Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy. ---
72  2016 ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. AMR, CR, CV, pAMR
73  2016 Magnetic resonance imaging of the transplanted pediatric heart as a potential predictor of rejection. ACR, BNP, CMR, ECVs, EFs, EMB, HR, HT, LGE
74  2016 Outcome, incidence and risk factors for stroke after pediatric heart transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry. CHD, HR
75  2016 Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation. BMI, HDL-C, PGD, TG
76  2016 Role of Soluble ST2 as a Marker for Rejection after Heart Transplant. sST2
77  2015 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). AEPC, ERS, ESC
78  2015 A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. ---
79  2015 International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report. DBDs, DCD, EVLP
80  2015 Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study. EMB, EMBs, pAMR, pAMR
81  2015 Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. BOS, CLAD
82  2015 Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients. AR, CRP, TropT
83  2015 The long-term influence of repetitive cellular cardiac rejections on left ventricular longitudinal myocardial deformation in heart transplant recipients. GLS, RSs
84  2015 Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression. CNI, DSA, MCS, rATG
85  2014 Antibody-mediated rejection after orthotopic heart transplantation: a 9-year single-institution experience. AMR, ECMO
86  2014 Comprehensive bio-imaging using myocardial perfusion reserve index during cardiac magnetic resonance imaging and high-sensitive troponin T for the prediction of outcomes in heart transplant recipients. CAV, CMR, hs-TnT, HT, LGE, MPRI
87  2014 Current status of heart transplantation in Taiwan. ECMO, VAD
88  2014 De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection. CAV, CIF, FN, TN-C
89  2014 Impact of adult congenital heart disease on survival and mortality after heart transplantation. ACHD
90  2014 Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention. CAV, CI, OHTs, PCI
91  2014 Lung reperfusion injury in patients after balloon angioplasty for pulmonary artery stenosis. ARI, RV/FA
92  2014 Lung transplantation: a treatment option in end-stage lung disease. ---
93  2014 Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. ---
94  2014 Pathologic diagnosis of antibody-mediated rejection in endomyocardial biopsy after heart transplantation based on renewed International Society for Heart and Lung Transplantation criteria. ACR, AMR, EMB
95  2014 Pediatric heart transplantation-indications and outcomes in the current era. CHD, PHTS
96  2014 Persistent mild lesions in coronary angiography predict poor long-term survival of heart transplant recipients. CAG, CAV, OHT
97  2014 Results of surveillance bronchoscopy after cadaveric lung transplantation: a Japanese single-institution study. BAL, CIB, SB, TBLB
98  2014 Update on pathology of antibody-mediated rejection in the lung allograft. AMR, DSAs
99  2013 A survey of current practice for antibody-mediated rejection in heart transplantation. AMR, DSA, IVIG
100  2013 Barriers to optimal palliative care of lung transplant candidates. ---